Laurence de Moerlooze | Chief Medical Officer
P95

Laurence De Moerlooze serves as Chief Medical Officer at P95, drawing on more than two decades of experience in vaccine R&D and clinical leadership. She began her career at GSK Biologicals, where over 15 years she played a central role in regulatory, medical, and strategic functions. Contributing to the development of several high-impact vaccines, including one targeting HPV. Her work later expanded at Takeda, where she led global vaccine programs focused on Zika and Norovirus. Before joining P95, Laurence spent four years as Executive Vice President and CMO at Bavarian Nordic, guiding the company’s clinical pipeline across infectious disease areas. She holds a PhD in Virology from the University of Liège and completed postdoctoral research in Canada, the UK, and Belgium